PubMed · 2006 · 28 citations · 4 references
Veterinary MedicineInfectious DiseasesNeurologyClinical BiochemistryDiagnostic MicrobiologyMedical MicrobiologyCentral Nervous System InfectionsCerebrospinal Fluid BiomarkersAdenosine Deaminase TestingCarcinomatous MeningitisCerebrospinal Fluid AnalysisCerebrospinal Fluid DiagnosisCerebrospinal Fluid DiagnosticsCryptococcal MeningitisMeningitis DetectionMeningitis Diagnosis
We studied adenosine deaminase (ADA) activity in cerebrospinal fluid (CSF) of 16 cases of tuberculous meningitis, 4 cases of cryptococcal meningitis, 5 cases of bacterial meningitis, 12 cases of eosinophilic meningitis, 26 cases of aseptic meningitis, 6 cases of carcinomatous meningitis and 108 cases with normal CSF. The mean CSF ADA values for the different groups were: 39.44 +/- 41.46, 13.00 +/- 7.43, 34.20 +/- 40.81, 3.17 +/- 4.82, 10.03 +/- 9.23, 8.67 +/- 13.60, and 2.58 +/- 2.90 U/I, respectively. Comparing the ADA activity between patients with tuberculous meningitis and non-tuberculous meningitis, the receiver-operating characteristic (ROC) curve identified a CSF ADA level of 15.5 U/I as the best cut-off value to differentiate between the two, with a sensitivity of 75% and a specificity of 93%, with an area under the curve of 0.92. When tuberculous meningitis was compared with aseptic and carcinomatous meningitis, the ROC curve identified a CSF ADA level of 19.0 U/I as the best cut-off value for differentiation, with a sensitivity of 69% and a specificity of 94%, with an area under the curve of 0.83. The level of CSF ADA may be useful as a complementary tool in the early diagnosis of tuberculous meningitis.
4
Corticosteroid in tuberculous meningitis.
Chotmongkol, Suthipun Jitpimolmard, Yupa Thavornpitak · PubMed · 1996 · 40 citations